发明名称 |
Cell-permeable protein inhibitors of calpain |
摘要 |
<p>Fusion proteins have been discovered that contain a calpastatin peptide and a signal sequence capable of delivering the fusion protein into a cell. These proteins can be used to inhibit calpain and, more specifically, to inhibit platelet aggregation or degranulation, to inhibit or reverse erythrocyte sickling, to inhibit a human immunodeficiency virus (HIV), or to inhibit unwanted cellular proliferation or migration.</p> |
申请公布号 |
AU1381499(A) |
申请公布日期 |
1999.05.24 |
申请号 |
AU19990013814 |
申请日期 |
1998.11.04 |
申请人 |
NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. |
发明人 |
DAVID A. POTTER;PAUL R. SKOLNIK |
分类号 |
A61K38/00;C07K7/08;C07K14/81;(IPC1-7):A61K38/02;A61K38/16;A61K38/10;C07K2/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|